The MD Magazine editors rounded up the 10 best stories from the past month â€“ did you read them all?
Now that March has come to an end, it’s time to take a look back at the stories that had us do a double take.
This month we learned that this year’s flu shot was definitely worth it, scientists are working to turn beer compounds into cancer-fighting agents — yes, really – and even an NFL official believes the CTE-football link. But if you missed these stories, don’t worry, the MD Magazine editors rounded them all up! Did you read them all?
A 19-month-old boy died from meningitis, an illness that can be prevented through vaccination.
Enjoying a cold brew during post-work happy hours is always a treat, but next time opt for an IPA.
Mammograms can detect more than cancer, as described in a recent study, so what are we waiting for? A Q&A with Khurram Nasir, MD, from Johns Hopkins dives into how they can find heart risk.
Douglas Slakey, MD, MPH, arrived at Tulane University Medical Center nearly a decade before the storm hit the city and was there after the storm cleared helping the institution rebuild while still providing a high level of care to patients throughout the catastrophic event.
The National Football League (NFL) has long upheld its position that effects from playing the game are not linked to the neurological disease called chronic traumatic encephalopathy (CTE). But for the first time, an official with the organization is acknowledging the connection.
Flu activity is in full swing in the United States, according to the US Centers for Disease Control and Prevention (CDC) with outbreaks reported in 33 states.
Tattoo aficionados who appreciate the creative license behind professional inking can now take solace in the potential health benefits of tattoos.
The first uterus transplant done in the United States has failed after less than two weeks, officials at Cleveland Clinic announced.
What do President Jimmy Carter and Kim Kardashian have in common? Well, probably nothing besides the fact that people’s perspectives on their health conditions were both examined in a recent study.
The drug flibanserin, approved last year by the FDA to enhance sexual desire in women entering menopause, apparently produces less-than-satisfying results.